Cargando…
Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
OBJECTIVES: We previously reported the diagnostic and prognostic performance of neurofilament light chain (NfL), TAR DNA-binding protein 43 (TDP-43), and total tau (t-tau) in cerebrospinal fluid (CSF) and plasma as amyotrophic lateral sclerosis (ALS) biomarkers. The present study aimed to elucidate...
Autores principales: | Kojima, Yuta, Kasai, Takashi, Noto, Yu-ichi, Ohmichi, Takuma, Tatebe, Harutsugu, Kitaoji, Takamasa, Tsuji, Yukiko, Kitani-Morii, Fukiko, Shinomoto, Makiko, Allsop, David, Teramukai, Satoshi, Mizuno, Toshiki, Tokuda, Takahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629269/ https://www.ncbi.nlm.nih.gov/pubmed/34843548 http://dx.doi.org/10.1371/journal.pone.0260323 |
Ejemplares similares
-
Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
por: Kasai, Takashi, et al.
Publicado: (2019) -
Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021) -
Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020) -
Risk factors for neuropsychiatric symptoms in patients with Parkinson’s disease during COVID-19 pandemic in Japan
por: Kitani-Morii, Fukiko, et al.
Publicado: (2021) -
Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2018)